Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The gonorrhea regimen and dialysis comments are preserved historical GlobalRPh content, not a statement of current guideline recommendations.
Check source scope before reading a dose
UCSF - ceftriaxone
Product / population
Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.
Renal method
No routine renal dose adjustment in the listed adult indications.
Source revision
Revision date not stated in the reviewed page.
Retrieved
2026-09-05
Local review status
Locally included source-specific summary. Regimen differences are not automatically resolved.
UCSF Infectious Diseases Management Program · Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.
Renal method: No routine renal dose adjustment in the listed adult indications. Source date: Revision date not stated in the reviewed page. Retrieved: 2026-09-05
Locally included source-specific summary. Regimen differences are not automatically resolved.
Dosing / renal protocol and limits
Adult IV regimens are not routinely reduced for kidney dysfunction or hemodialysis in this source. Standard treatment uses 2 g daily; UTI uses 1 g daily. Meningitis and enterococcal endocarditis treated with concomitant ampicillin use 2 g every 12 hours. Obesity (BMI >30) can warrant individualized higher dosing with ID/pharmacy input. The indication-specific regimen is retained rather than treating all renal patients as receiving one dose.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.